RBR-6m2fch进行中（未招募）未知
Bioactive Compound: nutritional therapy in the lipid and glycemic alterations caused by HIV infection in individuals using combined antiretroviral therapy
niversidade Federal de Mato Grosso do Sul0 个研究点开始时间: 2017年8月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 100Y（—）
入选标准
- •Having aged 18 years or more; being on ART using or not lipid-lowering or hypoglycemic medications; perform laboratory tests according to request and control medical; participate from beginning to end of study and having signed the Term of Free and Informed.
排除标准
- •Do not meet the inclusion protocol; Be a carrier of mental and renal diseases; Being pregnant; Be indigenous.
研究者
相似试验
尚未招募
2 期
A new Innovative Oral Bioadhesive Formulation Incorporated With Nano Hydroxyapatite and Acorus Calamus Rhizome Extract To Enhance Remineralization of White Spot Lesions during braces Treatment â?? A Randomized Controlled Trial.CTRI/2022/07/043628Dr Jerusha T
终止
不适用
Effect of Consuming a Bioactive Compound (EPP) on Joint Health in Healthy AdultsKnee DiscomfortNCT06650670Biosearch S.A.37
进行中（未招募）
1 期
To confirm the safety and efficacy of NEUROASPIS PLP10® in the treatment of individuals, who have been diagnosed with relapsing remitting multiple sclerosis (MS).Relapsing-Remitting Multiple Sclerosis (RRMS)MedDRA version: 19.0Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2015-003147-19-GRPALUPA Medical Ltd220
尚未招募
1 期
Peptide supplementation for improving nutritional status of cancer patientsCancerPACTR202202585571226South China University of Technology80
已完成
2 期
Probiotic preparation, VSL#3 as a support pharmaceutical therapy in cirrhotic patients for the treatment of minimal hepatic encephalopathy (MHE)CTRI/2008/091/000268CD Pharma India Pvt Ltd